Toxoplasma gondii is one of the most widespread parasites of great relevance to planetary health. It infects approximately one-third of the world population. T. gondii establishes itself in warm-blooded animals and causes adverse health outcomes, particularly in immunocompromised patients. T. gondii is also widely used as a model organism to study other related apicomplexan parasites, which requires a deeper understanding of its molecular biology. Type I strains (GT1 and RH) of T. gondii are considered the most virulent forms. The whole-genome sequencing of T. gondii annotated 8460 predicted gene models in the parasite. To this end, the proteogenomics technology allows harnessing of mass spectrometry (MS)-derived proteomic data to unravel new protein-coding genes, not to mention validation and correction of the existing gene models. In this study using the proteogenomic approach, we report the identification of 31 novel protein-coding genes while reannotating 88 existing gene models. Notably, the genome annotations were corrected for genes, such as SAG5C, GRA6, ROP4, ROP5, and ROP26. The associated proteins are known to play important roles in host–parasite interactions, particularly in relation to parasite virulence, suppression of host immune response, and distinctively pertinent for the survival of the parasite inside the host system. These new findings offer new insights, informing planetary health broadly and the knowledge base on T. gondii virulence specifically. The proteogenomics approach also provides a concrete example to study related apicomplexan organisms of relevance to planetary health, and so as to develop new diagnostics and therapeutics against toxoplasmosis and related diseases.
Get full access to this article
View all access options for this article.
References
1.
AngMY, LowTY, LeePY, NazarieWFWM, GuryevV, and JamalR. (2019). Proteogenomics: From next-generation sequencing (NGS) and mass spectrometry-based proteomics to precision medicine. Clin Chim Acta, 498, 38–46.
2.
BaerenfallerK, GrossmannJ, GrobeiMA, et al. (2008). Genome-scale proteomics reveals Arabidopsis thaliana gene models and proteome dynamics. Science, 320, 938–941.
3.
BansalP, AntilN, KumarM, et al. (2021). Protein kinase TgCDPK7 regulates vesicular trafficking and phospholipid synthesis in Toxoplasma gondii. PLoS Pathog, 17, e1009325.
4.
Barbosa-CabreraE, Salas-CasasA, Rojas-HernandezS, et al. (2012). Purification and cellular localization of the Entamoeba histolytica transcarboxylase. Parasitol Res, 111, 1401–1405.
5.
BehnkeMS, FentressSJ, MashayekhiM, LiLX, TaylorGA, and SibleyLD. (2012). The polymorphic pseudokinase ROP5 controls virulence in Toxoplasma gondii by regulating the active kinase ROP18. PLoS Pathog, 8, e1002992.
6.
BittameA, EffantinG, PètreG, et al. (2015). Toxoplasma gondii: Biochemical and biophysical characterization of recombinant soluble dense granule proteins GRA2 and GRA6. Biochem Biophys Res Commun, 459, 107–112.
7.
BorjaMS, PiotukhK, FreundC, and GrossJD. (2011). Dcp1 links coactivators of mRNA decapping to Dcp2 by proline recognition. RNA, 17, 278–290.
8.
BoucherLE, and BoschJ. (2015). The apicomplexan glideosome and adhesins–structures and function. J Struct Biol, 190, 93–114.
9.
BradleyPJ, and SibleyLD. (2007). Rhoptries: An arsenal of secreted virulence factors. Curr Opin Microbiol, 10, 582–587.
10.
BradleyPJ, WardC, ChengSJ, et al. (2005). Proteomic analysis of rhoptry organelles reveals many novel constituents for host-parasite interactions in Toxoplasma gondii. J Biol Chem, 280, 34245–34258.
11.
BrancaRM, OrreLM, JohanssonHJ, et al. (2014). HiRIEF LC-MS enables deep proteome coverage and unbiased proteogenomics. Nat Methods, 11, 59.
12.
CareyKL, JongcoAM, KimK, and WardGE. (2004). The Toxoplasma gondii rhoptry protein ROP4 is secreted into the parasitophorous vacuole and becomes phosphorylated in infected cells. Eukaryot Cell, 3, 1320–1330.
13.
CastellanaNE, PayneSH, ShenZ, StankeM, BafnaV, and BriggsSP. (2008). Discovery and revision of Arabidopsis genes by proteogenomics. Proc Natl Acad Sci U S A, 105, 21034–21038.
14.
ChaerkadyR, KelkarDS, MuthusamyB, et al. (2011). A proteogenomic analysis of Anopheles gambiae using high-resolution Fourier transform mass spectrometry. Genome Res, 21, 1872–1881.
15.
CheF-Y, Madrid-AlisteC, BurdB, et al. (2011). Comprehensive proteomic analysis of membrane proteins in Toxoplasma gondii. Mol Cell Proteomics, 10, M110.000745.
16.
ChoiS-H, KimTY, ParkSG, et al. (2010). Proteomic analysis of Toxoplasma gondii KI-1 tachyzoites. Korean J Parasitol, 48, 195.
17.
ChuiP, GinT, and ChungS. (1992). Anaesthesia for a patient undergoing transthoracic endoscopic vagotomy. Br J Anaesth, 68, 318–320.
18.
CohenA, RumpelK, CoombsG, and WastlingJ. (2002). Characterisation of global protein expression by two-dimensional electrophoresis and mass spectrometry: Proteomics of Toxoplasma gondii. Int J Parasitol, 32, 39–51.
19.
CowellAN, and WinzelerEA. (2019). Advances in omics-based methods to identify novel targets for malaria and other parasitic protozoan infections. Genome Med, 11, 1–17.
20.
Cruz-MirónR, Ramírez-FloresCJ, Lagunas-CortésN, et al. (2021). Proteomic characterization of the pellicle of Toxoplasma gondii. J Proteomics, 237, 104146.
21.
de LeónCTG, MartínRDD, HernándezGM, PozosSG, AmbrosioJR, and FloresRM. (2014). Proteomic characterization of the subpellicular cytoskeleton of Toxoplasma gondii tachyzoites. J Proteomics, 111, 86–99.
22.
DybasJM, Madrid-AlisteCJ, CheF-Y, et al. (2008). Computational analysis and experimental validation of gene predictions in Toxoplasma gondii. PLoS One, 3, e3899.
23.
DziadekB, GatkowskaJ, BrzostekA, DziadekJ, DzitkoK, and DlugonskaH. (2009). Toxoplasma gondii: The immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis. Exp Parasitol, 123, 81–89.
24.
FritzHM, BowyerPW, BogyoM, ConradPA, and BoothroydJC. (2012). Proteomic analysis of fractionated Toxoplasma oocysts reveals clues to their environmental resistance. PLoS One, 7, e29955.
25.
GajriaB, BahlA, BrestelliJ, et al. (2008). ToxoDB: An integrated Toxoplasma gondii database resource. Nucleic Acids Res, 36, D553–D556.
26.
GarfootAL, WilsonGM, CoonJJ, and KnollLJ. (2019). Proteomic and transcriptomic analyses of early and late-chronic Toxoplasma gondii infection shows novel and stage specific transcripts. BMC Genomics, 20, 1–11.
27.
HakimiM-A, OliasP, and SibleyLD. (2017). Toxoplasma effectors targeting host signaling and transcription. Clin Microbiol Rev, 30, 615–645.
28.
HanksSK, and HunterT. (1995). The eukaryotic protein kinase superfamily: Kinase (catalytic) domain structure and classification 1. FASEB J, 9, 576–596.
29.
HuK, JohnsonJ, FlorensL, et al. (2006). Cytoskeletal components of an invasion machine—The apical complex of Toxoplasma gondii. PLoS Pathog, 2, e13.
30.
KankovaS, and FlegrJ. (2007). Longer pregnancy and slower fetal development in women with latent “asymptomatic” toxoplasmosis. BMC Infect Dis, 7, 114.
31.
KatoK. (2018). How does Toxoplasma gondii invade host cells?. J Vet Med Sci, 80, 1702–1706.
32.
KhanA, BehnkeMS, DunayIR, WhiteMW, and SibleyLD. (2009). Phenotypic and gene expression changes among clonal type I strains of Toxoplasma gondii. Eukaryot Cell, 8, 1828–1836.
33.
KimM-S, PintoSM, GetnetD, et al. (2014). A draft map of the human proteome. Nature, 509, 575–581.
34.
KrishnaR, XiaD, SandersonS, et al. (2015). A large-scale proteogenomics study of apicomplexan pathogens—Toxoplasma gondii and Neospora caninum. Proteomics, 15, 2618–2628.
35.
LasonderE, IshihamaY, AndersenJS, et al. (2002). Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry. Nature, 419, 537–542.
36.
LazarIM, KarciniA, AhujaS, and Estrada-PalmaC. (2019). Proteogenomic analysis of protein sequence alterations in breast cancer cells. Sci Rep, 9, 1–13.
37.
LeeE-g, KimJ-h, ShinY-s, et al. (2005). Application of proteomics for comparison of proteome of Neospora caninum and Toxoplasma gondii tachyzoites. J Chromatogr B Analyt Technol Biomed Life Sci, 815, 305–314.
38.
LetunicI, KhedkarS, and BorkP. (2021). SMART: Recent updates, new developments and status in 2020. Nucleic Acids Res, 49, D458–D460.
39.
LvL, WangY, FengW, et al. (2017). iTRAQ-based differential proteomic analysis in Mongolian gerbil brains chronically infected with Toxoplasma gondii. J Proteomics, 160, 74–83.
40.
MüllerJ, and HemphillA. (2016). Drug target identification in protozoan parasites. Expert Opin Drug Discov, 11, 815–824.
41.
NiedelmanW, GoldDA, RosowskiEE, et al. (2012). The rhoptry proteins ROP18 and ROP5 mediate Toxoplasma gondii evasion of the murine, but not the human, interferon-gamma response. PLoS Pathog, 8, e1002784.
42.
NirujogiRS, PawarH, RenuseS, et al. (2014). Moving from unsequenced to sequenced genome: Reanalysis of the proteome of Leishmania donovani. J Proteomics, 97, 48–61.
43.
PrasadTK, HarshaH, KeerthikumarS, et al. (2012). Proteogenomic analysis of Candida glabrata using high resolution mass spectrometry. J Proteome Res, 11, 247–260.
44.
PrasadTK, MohantyAK, KumarM, et al. (2017). Integrating transcriptomic and proteomic data for accurate assembly and annotation of genomes. Genome Res, 27, 133–144.
45.
QiuW, WernimontA, TangK, et al. (2009). Novel structural and regulatory features of rhoptry secretory kinases in Toxoplasma gondii. EMBO J, 28, 969–979.
46.
Ramírez-FloresCJ, Cruz-MirónR, Mondragón-CastelánME, González-PozosS, Ríos-CastroE, and Mondragón-FloresR. (2019). Proteomic and structural characterization of self-assembled vesicles from excretion/secretion products of Toxoplasma gondii. J Proteomics, 208, 103490.
47.
RobinsonJT, ThorvaldsdóttirH, WengerAM, ZehirA, and MesirovJP. (2017). Variant review with the integrative genomics viewer. Cancer Res, 77, e31–e34.
48.
RoosDS, CrawfordMJ, DonaldRG, et al. (1999). Transport and trafficking: Toxoplasma as a model for Plasmodium. Novartis Foundation Symposium, London, United Kingdom. Wiley Online Library, 176–198.
49.
RospertS, DubaquieY, and GautschiM. (2002). Nascent-polypeptide-associated complex. Cell Mol Life Sci, 59, 1632–1639.
50.
SeidiA, Muellner-WongLS, RajendranE, et al. (2018). Elucidating the mitochondrial proteome of Toxoplasma gondii reveals the presence of a divergent cytochrome c oxidase. Elife, 7, e38131.
51.
SidikSM, HuetD, GanesanSM, et al. (2016). A genome-wide CRISPR screen in Toxoplasma identifies essential apicomplexan genes. Cell, 166, 1423–1435.e12.
52.
StankeM, SteinkampR, WaackS, and MorgensternB. (2004). AUGUSTUS: A web server for gene finding in eukaryotes. Nucleic Acids Res, 32, W309–W312.
53.
StelzerS, BassoW, Benavides SilvanJ, et al. (2019). Toxoplasma gondii infection and toxoplasmosis in farm animals: Risk factors and economic impact. Food Waterborne Parasitol, 15, e00037.
54.
TenterAM, HeckerothAR, and WeissLM. (2000). Toxoplasma gondii: From animals to humans. Int J Parasitol, 30, 1217–1258.
55.
TuV, MayoralJ, SugiT, et al. (2019). Enrichment and proteomic characterization of the cyst wall from in vitro Toxoplasma gondii cysts. mBio, 10, e00469-19.
56.
WangZ-X, ZhouC-X, ElsheikhaHM, HeS, ZhouD-H, and ZhuX-Q. (2017a). Proteomic differences between developmental stages of Toxoplasma gondii revealed by iTRAQ-based quantitative proteomics. Front Microbiol, 8, 985.
57.
WangZD, LiuHH, MaZX, et al. (2017b). Toxoplasma gondii infection in immunocompromised patients: A systematic review and meta-analysis. Front Microbiol, 8, 389.
58.
WeissLM, and DubeyJP. (2009). Toxoplasmosis: A history of clinical observations. Int J Parasitol, 39, 895–901.
59.
XiaD, SandersonSJ, JonesAR, et al. (2008). The proteome of Toxoplasma gondii: Integration with the genome provides novel insights into gene expression and annotation. Genome Biol, 9, 1–18.
60.
ZhangY, LaiBS, JuhasM, and ZhangY. (2019). Toxoplasma gondii secretory proteins and their role in invasion and pathogenesis. Microbiol Res, 227, 126293.
61.
ZhouC-X, ZhuX-Q, ElsheikhaHM, et al. (2016). Global iTRAQ-based proteomic profiling of Toxoplasma gondii oocysts during sporulation. J Proteomics, 148, 12–19.
62.
ZhouDH, ZhaoFR, NisbetAJ, et al. (2014). Comparative proteomic analysis of different Toxoplasma gondii genotypes by two-dimensional fluorescence difference gel electrophoresis combined with mass spectrometry. Electrophoresis, 35, 533–545.
63.
ZhouXW, KafsackBF, ColeRN, BeckettP, ShenRF, and CarruthersVB. (2005). The opportunistic pathogen Toxoplasma gondii deploys a diverse legion of invasion and survival proteins. J Biol Chem, 280, 34233–34244.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
